Log In
BCIQ
Print this Print this
 

TTT-3002

  Manage Alerts
Collapse Summary General Information
Company TauTaTis Inc.
DescriptionLeucine-rich repeat kinase 2 (LRRK2) inhibitor
Molecular Target Leucine-rich repeat kinase 2 (LRRK2)
Mechanism of ActionKinase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today